These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1140243)

  • 21. 9 -Tetrahydrocannabinol and its metabolites in monkey brains.
    Ho BT; Estevez V; Englert LF; McIsaac WM
    J Pharm Pharmacol; 1972 May; 24(5):414-6. PubMed ID: 4403817
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolism and autoradiographic distribution of delta-8- and delta-9-tetrahydrocannabinol in some organs of the monkey Callithrix jacchus.
    Just WW; Erdmann G; Thel S; Werner G; Wiechmann M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):219-25. PubMed ID: 806815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between the subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in rat brain and the duration of the effect on motor activity.
    Magour S; Coper H; Fähndrich C; Hill R
    Life Sci; 1976 Mar; 18(6):575-84. PubMed ID: 1263740
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood and brain levels of delta1-tetrahydrocannabinol in mice--the effect of 7-hydroxy-delta1-tetrahydrocannabinol.
    Gill EW; Lawrence DK
    Biochem Pharmacol; 1974 Mar; 23(6):1140-3. PubMed ID: 4824912
    [No Abstract]   [Full Text] [Related]  

  • 25. The distribution and excretion of tetrahydrocannabinol-C 14 in humans.
    Miras C; Coutselinis A
    Med Sci Law; 1971 Oct; 11(4):197-9. PubMed ID: 5148725
    [No Abstract]   [Full Text] [Related]  

  • 26. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK; Pertwee RG
    Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.
    Agurell S; Carlsson S; Lindgren JE; Ohlsson A; Gillespie H; Hollister L
    Experientia; 1981 Oct; 37(10):1090-2. PubMed ID: 6273208
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism of delta 9 -tetrahydrocannabinol by lung and liver homogenates of rats treated with methylcholanthrene.
    Nakazawa K; Costa E
    Nature; 1971 Nov; 234(5323):48-9. PubMed ID: 4942885
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transformation of delta-1-tetrahydrocannabinol (THC) by rabbit liver microsomes.
    Ben-Zvi Z; Burstein S
    Biochem Pharmacol; 1975 May; 24(10):1130-1. PubMed ID: 1156437
    [No Abstract]   [Full Text] [Related]  

  • 31. Mass fragmentographic assay for 11-hydroxy-delta 9-tetrahydrocannabinol from plasma.
    Rosenfeld JM; Taguchi VY
    Anal Chem; 1976 Apr; 48(4):726-9. PubMed ID: 1259165
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 33. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.
    Kemp PM; Abukhalaf IK; Manno JE; Manno BR; Alford DD; Abusada GA
    J Anal Toxicol; 1995 Sep; 19(5):285-91. PubMed ID: 7500614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood levels of 3 H- 9 -tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons.
    McMillan DE; Dewey WL; Turk RF; Harris LS; McNeil JH
    Biochem Pharmacol; 1973 Feb; 22(3):383-97. PubMed ID: 4687134
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of cannabinol delta1-tetrahydro-cannabinol clearance from the blood.
    McCallum NK
    Experientia; 1975 Aug; 31(8):957-8. PubMed ID: 1157869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The physiologic disposition of marihuana in man.
    Lemberger L; Rubin A
    Life Sci; 1975 Dec; 17(11):1637-42. PubMed ID: 1107735
    [No Abstract]   [Full Text] [Related]  

  • 37. Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man.
    Widman M; Agurell S; Ehrnebo M; Jones G
    J Pharm Pharmacol; 1974 Nov; 26(11):914-6. PubMed ID: 4156569
    [No Abstract]   [Full Text] [Related]  

  • 38. Letter: Metabolism of delta 1-tetrahydrocannabinol by mouse hepatic microsomes: identification of 6alpha-hydroxytetrahydrocannabinol.
    Ben-Zvi Z; Burstein S; Zikopoulos J
    J Pharm Sci; 1974 Jul; 63(7):1173-4. PubMed ID: 4852855
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of (-)-delta 9-6a,10a-trans-tetrahydrocannabinol and two of its metabolites in rats by use of combination gas chromatography-mass spectrometry and mass fragmentography.
    Mikes F; Hofmann A; Waser PG
    Biochem Pharmacol; 1971 Sep; 20(9):2469-76. PubMed ID: 4355783
    [No Abstract]   [Full Text] [Related]  

  • 40. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol.
    Hollister LE
    Pharmacology; 1974; 11(1):3-11. PubMed ID: 4610598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.